Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Treatment Effect in Pulmonary Sarcoidosis
NL-OMON20636Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisone in pulmonary sarcoidosis and sarcoidosis, sponsored by Erasmus MC. Primary endpoint: Repeated measurements of forced vital capacity and prednisone dose used. Started Dec 2013; status: active, not recruiting.
02
Drugs
prednisone
03
Conditions
pulmonary sarcoidosissarcoidosis
Beyond the preview
Go deeper on NL-OMON20636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20636.